Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M203539200 on May 9, 2002

J. Biol. Chem., Vol. 277, Issue 29, 25970-25975, July 19, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/29/25970    most recent
M203539200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krnajski, Z.
Right arrow Articles by Müller, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krnajski, Z.
Right arrow Articles by Müller, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thioredoxin Reductase Is Essential for the Survival of Plasmodium falciparum Erythrocytic Stages*

Zita KrnajskiDagger §, Tim-Wolf GilbergerDagger ||, Rolf D. WalterDagger , Alan F. Cowman||, and Sylke MüllerDagger **Dagger Dagger

From the Dagger  Bernhard Nocht Institute for Tropical Medicine, Department of Biochemical Parasitology, 20359 Hamburg, Germany,  The Walter and Eliza Hall Institute of Medical Research, P. O. Royal Melbourne Hospital, 3050 Melbourne, Victoria, Australia, and ** University of Dundee, School of Life Sciences, Dundee DD1 5EH, Scotland, United Kingdom

The human malaria parasite Plasmodium falciparum poses an increasing threat to human health in the tropical regions of the world, and the validation and assessment of possible drug targets is required for the development of new antimalarials. It has been shown that the erythrocytic stages of the parasites, which are responsible for the pathology of the disease in humans, are under enhanced oxidative stress and are particularly vulnerable to exogenous challenges by reactive oxygen species. Therefore it is postulated that the disruption of the antioxidant and/or redox systems of the parasite is a feasible way to interfere with their development during erythrocytic schizogony. In order to test this suggestion thioredoxin reductase (TrxR), an enzyme heavily involved in maintenance of redox homeostasis and antioxidant defense, was knocked out in P. falciparum. It was impossible to generate parasites with a disrupted trxR gene suggesting that TrxR is essential for P. falciparum erythrocytic stages. Technical problems were excluded by transfecting a 3' replacement construct, which recombined correctly and transfectants did not show any phenotypic alterations. In order to prove that the trxR knockout was responsible for the lethal phenotype of the null mutants, a co-transfection with both the knockout construct and a construct containing the trxR coding region under the control of the calmodulin promoter was conducted. Despite the disruption of the trxR gene, parasites were viable. In a Southern blot analysis a complicated restriction pattern was obtained, but it was shown by pulse field gel electrophoresis and field inverse gel electrophoreses that only the trxR gene locus on chromosome 9 was targeted by the constructs. It was found that the co-transfected constructs form concatemeric structures prior to integration into the trxR gene locus, which is further supported by plasmid rescue followed by restriction analyses of the plasmids. Northern and Western blot analyses proved that the co-transfectants highly overexpress TrxR from the introduced gene. Our results demonstrate that TrxR is essential for the survival of the erythrocytic stages of P. falciparum.


* This work was supported in part by the Deutsche Forschungsgemeinschaft Grants DFG MU837/1-1 and DFG WA395/14-4 and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Performed this work as part of a doctoral study at the Faculty of Biology, University of Hamburg, Germany.

|| Recipient of an Emmy-Nöther-Fellowship.

Dagger Dagger Wellcome Trust Senior Fellow. To whom correspondence should be addressed: University of Dundee, School of Life Sciences, Division of Biological Chemistry and Molecular Microbiology, MSI/WTB Complex, Dundee DD1 5EH, Scotland, UK. Tel.: 44-1382-345760; Fax: 44-1382- 345764; E-mail: s.muller@dundee.ac.uk.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. J. McMillan, L. D. Arscott, D. P. Ballou, K. Becker, C. H. Williams Jr., and S. Muller
Identification of Acid-Base Catalytic Residues of High-Mr Thioredoxin Reductase from Plasmodium falciparum
J. Biol. Chem., November 3, 2006; 281(44): 32967 - 32977.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. M. Massimine, M. T. McIntosh, L. T. Doan, C. E. Atreya, S. Gromer, W. Sirawaraporn, D. A. Elliott, K. A. Joiner, R. H. Schirmer, and K. S. Anderson
Eosin B as a Novel Antimalarial Agent for Drug-Resistant Plasmodium falciparum.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3132 - 3141.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
T. A. Missall and J. K. Lodge
Thioredoxin Reductase Is Essential for Viability in the Fungal Pathogen Cryptococcus neoformans
Eukaryot. Cell, February 1, 2005; 4(2): 487 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Akerman and S. Muller
Peroxiredoxin-linked Detoxification of Hydroperoxides in Toxoplasma gondii
J. Biol. Chem., January 7, 2005; 280(1): 564 - 570.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
I. Yeh, T. Hanekamp, S. Tsoka, P. D. Karp, and R. B. Altman
Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery
Genome Res., May 1, 2004; 14(5): 917 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Campanale, C. Nickel, C. A. Daubenberger, D. A. Wehlan, J. J. Gorman, N. Klonis, K. Becker, and L. Tilley
Identification and Characterization of Heme-interacting Proteins in the Malaria Parasite, Plasmodium falciparum
J. Biol. Chem., July 18, 2003; 278(30): 27354 - 27361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement